APO GLP 5 (Glipizide 5 mg)
Pill imprint APO GLP 5 has been identified as Glipizide 5 mg.
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- APO GLP 5
- 5 mg
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Apotex Corporation
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|66267-0100||Nucare Pharmaceuticals Inc (repackager)|
|66336-0730||Dispensing Solutions Inc. (repackager)|
|54868-3318||Physicians Total Care Inc (repackager)|
|21695-0469||Rebel Distributors Corp (repackager)|
|49999-0108||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about glipizide
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.